A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days
Stopped One cohort succesfully completed; further cohorts not needed, no safety issue.
Conditions
Interventions
- DEVICE: FiberSense System
Sponsor
EyeSense GmbH